Manufacture of recombinant polyclonal antibodies

Biotechnology Letters

Volumn 29, Issue 6, 2007, Pages 845-852

  Rasmussen, S K ^a   Rasmussen, L K ^a   Weilguny, D ^a   Tolstrup, A B ^a  

^a Symphogen AS   (Denmark)

Author keywords

Hemolytic disease of the newborn; Idiopathic thrombocytopenic purpura; Mammalian expression; Recombinant polyclonal antibody

Indexed keywords

HEMOLYTIC DISEASE OF THE NEWBORN; HEMOLYTIC DISEASES; MAMMALIAN EXPRESSIONS; RECOMBINANT POLYCLONAL ANTIBODIES;

ANTIBODIES; CELLS; DISEASES; GENETIC ENGINEERING; IMMUNOLOGY;

DRUG THERAPY;

ANTISERUM; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; RHO(D) ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; BLOOD GROUP RHESUS SYSTEM; GENETICS; HUMAN; IMMUNOLOGY; REVIEW;

ANIMALS; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNE SERA; MODELS, IMMUNOLOGICAL; RECOMBINANT PROTEINS; RH-HR BLOOD-GROUP SYSTEM;

MAMMALIA;

EID: 34247344863     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-007-9331-8     Document Type: Review

References (21)

1. Barnes LM, Bentley CM, Dickson AJ (2003) Stability of protein production from recombinant mammalian cells. Biotechnol Bioeng 81:631-639
2. Brezinsky SC, Chiang GG, Szilvasi A, Mohan S, Shapiro RI, MacLean A, Sisk W, Thill G (2003) A simple method for enriching populations of transfected CHO cells for cells of higher specific productivity. J Immunol Methods 277:141-155
3. Casadevall A, Dadachova E, Pirofski LA (2004) Passive antibody therapy for infectious diseases. Nature Rev Microbiol 2:695-703
4. Casadevall A, Scharff MD (1995) Return to the past: the case for antibody-based therapies in infectious diseases. Clin Infect Dis 21:150-161
5. Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, McKinney P, McNally J, Kitchens CS, Curry SC, Bogdan GM, Ward SB, Porter RS (2001) A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med 161:2030-2036
6. European Agency for the Evaluation of Medicinal Products (1995) Production and quality control of monoclonal antibodies (1995). Directive 75/318/EEC 3AB4a. 237-262
7. Food and Drug Administration, Center for Biologics Evaluation and Research (1997) Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human use. pp 1-50
8. Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497
9. Newcombe C, Newcombe AR (2006) Antibody production: Polyclonal-derived biotherapeutics. J Chromatogr B Analyt Technol Biomed Life Sci
10. Nowakowski A, Wang C, Powers DB, Amersdorfer P, Smith TJ, Montgomery VA, Sheridan R, Blake R, Smith LA, Marks JD (2002) Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc Natl Acad Sci USA 99:11346-11350
11. Rasmussen LK, Frandsen TP, Rasmussen SK, Andersen PS (2006) A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line. World patent WO 2006/007853 A2
12. Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC (2005) Monoclonal antibody successes in the clinic. Nature Biotechnol 23:1073-1078
13. Rice TW, Wheeler AP, Morris PE, Paz HL, Russell JA, Edens TR, Bernard GR (2006) Safety and efficacy of affinity-purified, anti-tumor necrosis factor-alpha, ovine fab for injection (CytoFab) in severe sepsis. Crit Care Med 34:2271-2281
14. Sarantopoulos S, Kao CY, Den W, Sharon J (1994) A method for linking VL and VH region genes that allows bulk transfer between vectors for use in generating polyclonal IgG libraries. J Immunol 152:5344-5351
15. Scaradavou A, Woo B, Woloski BMR, Cunningham-Rundles C, Ettinger LJ, Aledort LM, Bussel JB (1997) Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients. Blood 89:2689-2700
16. Schenerman MA, Sunday BR, Kozlowski S, Webber K, Gazzano-Santoro H, Mire-Sluis A (2004) CMC strategy forum report. Analysis and structural characterization of monoclonal antibodies. BioProcess Int 2:42-52
17. Sharon J, Liebman MA, Williams BR (2005) Recombinant polyclonal antibodies for cancer therapy. J Cell Biochem 96:305-313
18. Wiberg FC, Rasmussen SK, Frandsen TP, Rasmussen LK, Tengbjerg K, Coljee VW, Sharon J, Yang CY, Bregenholt S, Nielsen LS, Haurum JS, Tolstrup AB (2006) Production of target-specific recombinant human polyclonal antibodies in mammalian cells. Biotechnol Bioeng 94:396-405
19. Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnol 22:1393-1398
20. Yoon SK, Kim SH, Lee GM (2003) Effect of low culture temperature on specific productivity and transcription level of anti-4-1BB antibody in recombinant Chinese hamster ovary cells. Biotechnol Prog 19:1383-1386
21. Zahn-Zabal M, Kobr M, Girod PA, Imhof M, Chatellard P, De Jesus M, Wurm F, Mermod N (2001) Development of stable cell lines for production or regulated expression using matrix attachment regions. J Biotechnol 87:29-42